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Abstract
Immune responses have the important function of host defense and protection against pathogens. However, the immune
response also causes inflammation and host tissue injury, termed immunopathology. For example, hepatitis B and C virus
infection in humans cause immunopathological sequel with destruction of liver cells by the host’s own immune response.
Similarly, after infection with lymphocytic choriomeningitis virus (LCMV) in mice, the adaptive immune response causes liver
cell damage, choriomeningitis and destruction of lymphoid organ architecture. The immunopathological sequel during
LCMV infection has been attributed to cytotoxic CD8+ T cells. However, we now show that during LCMV infection CD4+ T
cells selectively induced the destruction of splenic marginal zone and caused liver cell damage with elevated serum alanin-
transferase (ALT) levels. The destruction of the splenic marginal zone by CD4+ T cells included the reduction of marginal
zone B cells, marginal zone macrophages and marginal zone metallophilic macrophages. Functionally, this resulted in an
impaired production of neutralizing antibodies against LCMV. Furthermore, CD4+ T cells reduced B cells with an
IgMhighIgDlow phenotype (transitional stage 1 and 2, marginal zone B cells), whereas other B cell subtypes such as follicular
type 1 and 2 and germinal center/memory B cells were not affected. Adoptive transfer of CD4+ T cells lacking different
important effector cytokines and cytolytic pathways such as IFNc, TNFa, perforin and Fas-FasL interaction did reveal that
these cytolytic pathways are redundant in the induction of immunopathological sequel in spleen. In conclusion, our results
define an important role of CD4+ T cells in the induction of immunopathology in liver and spleen. This includes the CD4+ T
cell mediated destruction of the splenic marginal zone with consecutively impaired protective neutralizing antibody
responses.
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Introduction
Immune protection against pathogens must be balanced co-
evolutionarily against lethal damage by immune responses. The
process of host tissue destruction by the own immune system is
termed immunopathology. Immunopathological sequel occurs
during important infections in humans and mice. For example,
after infection with hepatitis B and C virus in men, the T cell
response causes liver cell damage. Similarly, the T cell response
against lymphocytic choriomeningitis virus (LCMV) leads to
destruction of secondary lymphoid organs, hepatic damage and
choriomeningitis [1,2].
Secondary lymphoid organs are highly organized structures,
where B and T cells are localized to specialized zones. In contrast to
lymph nodes, the lymphoid compartment of the spleen contains an
additional structure called marginal zone, which consists of
marginal zone macrophages, marginal zone metallophilic macro-
phages and marginal zone B cells [3]. Non-hematopoietic stromal
cells orchestrate the structure of secondary lymphoid organs by
expression of chemokines such as CCL19, CCL21, and CXCL13.
The integrity of lymphoid organ architecture provides the basis for
an optimal adaptive immune response. Mice with disturbed
lymphoid organ architecture such as alymphoplastic (aly/aly),
LTbR2/2, LTb2/2, LTa2/2 and TNFa2/2 mice have defects in
the adaptive immune response of varying degree [4]. In addition to
LCMV, destruction of lymphoid architecture is caused by several
pathogens such as HIV [5], Plasmodium falciparum (malaria) [6] and
Lassa virus [7] in men and Leishmania donovani [8], Borrelia crocidurae
(relapsing fever) [9] and murine cytomegalovirus [10] in mice. The
destruction of secondary lymphoid organs is therefore an effective
strategy employed by pathogens to suppress the host’s immune
system. The mechanisms of lymphoid organ architecture destruc-
tion are poorly defined in most of these infections, yet cytotoxic
effects of the host’s immune system may play a central role.
Immunopathology after LCMV infection has generally been
attributed to cytotoxic CD8+ T cells, because CD8+ T cell
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depletion prevented the destruction of lymphoid organ architec-
ture and hepatic damage [1,11,12]. However, in the absence of
CD8+ T cells, viral load remains at high titers until approximately
40 days after infection when LCMV-specific neutralizing antibod-
ies are mounted [13]. Importantly, the high virus load leads to
functional inactivation of CD4+ T cells. The functional inactiva-
tion of CD4+ T cells is most likely a result of continued triggering
by high viral load in combination with other parameters such as
inflammatory cytokines, and expression of inhibitory receptors or
pro-apoptotic molecules [14]. This is a relevant limitation of the
CD8+ T cell-depletion experiments, and therefore a role of CD4+
T cells in the induction of immunopathology during LCMV-
infection cannot be excluded.
Here, we studied the role of CD4+ T cells in the destruction of
splenic architecture and hepatic damage during LCMV infection.
To restore CD4+ T cell function, CD8-depleted BL/6 mice were
adoptively transferred with LCMV-immune CD4+ T cells or
LCMV-GP61-specific T cell receptor transgenic (SMARTA [15])
CD4+ T cells. We found that functional CD4+ T cells selectively
destroy the splenic marginal zone, reduce protective LCMV-
neutralizing antibodies and exert liver cell damage. Therefore, our
results define an important role of CD4+ T cells in the induction of
immunopathology in spleen and liver after LCMV infection.
Results
Adoptive transfer of LCMV-specific CD4+ T cells to CD8+ T
cell-depleted mice rescues CD4+ T cell function in LCMV
infection
BL/6 mice clear LCMV-WE doses of up to 106 pfu within two
weeks after infection below the detection limit of conventional
plaque forming assays [16]. Control of LCMV is primarily
mediated by cytotoxic CD8+ T cells and depletion of CD8+ T cells
leads to high viremia until antibodies are mounted approximately
40 days after infection [13]. To analyze the function of LCMV-
specific CD4+ T cells in the absence of CD8+ T cells and high
viremia, BL/6 mice were depleted of CD8+ T cells by monoclonal
antibody and infected with LCMV. As shown previously [13],
CD8+ T cell depletion resulted in a drastic reduction of the relative
and absolute number of LCMV-specific CD4+ T cells producing
IFNc and TNFa on day 8 and 11 after infection (Fig. 1A,B). For
example on day 11, the mean percentage of CD4+ T cell
producing IFNc after restimulation with GP61 decreased
significantly from 0.63% to 0.05% and the mean absolute number
of IFNc-producing CD4+ T cells dropped significantly from
0.656105 to 0.0856105.
In order to obtain functional LCMV-specific CD4+ T cells in
CD8-depleted BL/6 mice, the following experiment was per-
formed: First, naı¨ve BL/6 mice were depleted of CD8+ T cells by
monoclonal antibody. On the same day, splenocytes of LCMV-
infected BL/6 mice (17 days post infection) were harvested,
purified for CD4+ T cells by MACS and adoptively transferred i.v.
to these naı¨ve CD8-depleted BL/6 mice. Each mouse received
1.56107 purified CD4+ T cells, which contained about 2.56105
IFNc-producing LCMV GP61-specific CD4+ T cells (data not
shown). Subsequently, mice were infected with LCMV (106 pfu).
On day 8 and 11 after infection CD4+ T cell function was
analyzed in spleen. The transfer of purified LCMV-immune CD4+
T cells to CD8-depleted mice largely restored the relative and
absolute number of LCMV-specific CD4+ T cells producing IFNc
at day 8 and 11 after infection (Fig. 1A,B). Furthermore, it
increased the relative and absolute numbers of LCMV-specific
CD4+ T cells producing TNFa on day 11, but not on day 8 after
infection (Fig. 1A,B). In analogy, the adoptive transfer of naive
LCMV-GP61-specific CD4+ T cells (transgenic SMARTA [15]
cells) to CD8-depleted BL/6 mice increased the number of IFNc-
producing and to a lesser extent of TNFa-producing LCMV-
specific CD4+ T cells on day 11 after LCMV infection (Fig. 1C).
Importantly, CD4+ T cell function after adoptive transfer to CD8-
depleted BL/6 mice was comparable to that observed in CD8+ T
cell competent BL/6 mice. Therefore, this experimental set-up
allows us to analyze the role of CD4+ T cells in the induction of
immunopathology at a physiological frequency in the absence of
CD8+ T cells.
Adoptive transfer of LCMV-immune CD4+ T cells to CD8-
depleted BL/6 mice did not reduce the viral load in spleen or liver
on day 11 after infection (Fig. 2A). In contrast, LCMV elimination
was dependent on CD8+ T cells. Similarly, adoptive transfer of
naive SMARTA cells did not influence viral elimination in spleen
(data not shown).
Reduced neutralizing antibody titers after transfer of
activated CD4+ T cells
To test the consequence of adoptively transferred CD4+ T cells
on antibody production, we measured LCMV-specific neutralizing
antibodies under the same experimental conditions as described
for Figure 1A and B. LCMV-specific neutralizing antibodies in
BL/6 mice evolved late, 60–80 days after infection, and were of
low magnitude (Fig. 2B). In contrast, BL/6 mice depleted of CD8+
T cells produced LCMV-specific neutralizing antibodies earlier
and at higher titers (Fig. 2B). Interestingly, the adoptive transfer of
LCMV-immune CD4+ T cells to CD8-depleted BL/6 mice
significantly reduced neutralizing antibody titers. Therefore, CD4+
T cells impede the production of LCMV-specific neutralizing
antibodies.
Intact splenic T and B cell regions after transfer of
activated CD4+ T cells
Reduced production of LCMV-specific neutralizing antibodies
has been linked to the destruction of splenic architecture [1,16].
Therefore, we performed immunofluorescence microscopy anal-
ysis on histological slides 11 days after LCMV infection from
spleens of BL/6, CD8-depleted BL/6 and CD8-depleted BL/6
mice receiving LCMV-immune CD4+ T cells (Fig. 3A). LCMV-
infected BL/6 mice had disrupted white pulp structures, as shown
by staining for CD3+ T cells and B220+ B cells. In addition,
follicular dendritic cells (FDCs, CD35+BP3+Desmin+), represent-
ing stromal cells of the B cell zone were strongly reduced. The
networks of fibroblastic reticular cells (FRCs, gp38+desmin+),
representing stromal cells of the T cell zone, were less reticular in
LCMV-infected BL/6 mice. In contrast, in CD8-depleted BL/6
mice, B cell regions including FDC networks were preserved, while
T cell regions including FRC networks were still partially
disrupted. Interestingly, adoptive transfer of LCMV-immune
CD4+ T cells to CD8-depleted BL/6 mice did not lead to a
further disorganization of B and T cell regions including FDC and
FRC networks when compared to CD8-depleted mice.
In a next experiment, the expression of the chemokines
CXCL13, CCL19, and CCL21 was analyzed by quantitative
PCR in the spleen (Fig. 3B). These chemokines are produced by
FDCs and FRCs and are important for B and T zone
compartmentalization [3]. LCMV-infected BL/6 mice showed a
vigorous reduction of chemokine expression 11 days after infection
[11], which was less pronounced in CD8-depleted mice [17].
Importantly, CD8-depleted mice receiving LCMV-immune CD4+
T cells did not show a statistically significant difference of
chemokine levels to CD8-depleted mice. In accordance, immu-
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nofluorescence microscopy analysis of CXCL13 and CCL21
protein expression showed a strong reduction in LCMV infected
BL/6 mice (Fig. S1). Both chemokines were less reduced in CD8-
depleted mice without a clear difference to CD8-depleted mice
receiving LCMV-immune CD4+ T cells. Taken together, these
experiments revealed that the adoptive transfer of CD4+ T cells to
CD8-depleted mice neither contributed to a substantial destruc-
tion of the splenic white pulp nor to a reduction of CCL19,
CCL21, and CXCL13 expression.
Destruction of the splenic marginal zone by CD4+ T cells
Under the same experimental conditions, the integrity of the
splenic marginal zone was analyzed by immunohistochemical
staining of ER-TR9+ marginal zone macrophages (MZM) and
MOMA-1+ (CD169+) marginal zone metallophilic macrophages
(MOMA). The splenic marginal zone was largely destroyed in
immunocompetent BL/6 mice 11 days after LCMV infection with
reduced numbers of MZM and MOMA (Fig. 4A,B). In contrast,
CD8-depleted BL/6 mice retained the marginal zone with
numbers of MZM and MOMA comparable to naı¨ve BL/6 mice
(Fig. 4A,B). Interestingly, adoptive transfer of LCMV-immune
CD4+ T cells to CD8-depleted BL/6 mice destroyed the marginal
zone with reduced numbers of MZM and MOMA, comparable
to LCMV-infected control BL/6 mice (Fig. 4A,B). Therefore,
CD4+ T cells destroy lymphoid architecture in the absence of
CD8+ T cells and their effect is focused to the marginal zone of the
spleen.
Analysis of B cell subtypes
We next wanted to define the effect of LCMV-specific CD4+ T
cells on defined B cell subsets in the spleen. As described by
Allman et al [18] and shown in Fig. 5A, splenic CD19+ B cells can
be subdivided using multicolour flow cytometry into following
groups: (i) IgMhighIgDlow B cells, which contain transitional stage 1
(T1) B cells, transitional stage 2 (T2) B cells, and marginal zone
(MZ) B cells, (ii) IgMlowIgDhigh B cells representing follicular type I
Figure 1. Model to study LCMV-specific CD4+ T cell responses in the absence of CD8+ T cells. (A,B) BL/6 mice, BL/6 mice depleted of CD8+
T cells and BL/6 mice depleted of CD8+ T cells receiving 1.56107 purified LCMV-immune CD4+ T cells were infected with LCMV. On day 8 (A) and 11
(B) after infection, CD4+ splenocytes were restimulated in vitro for 5 h with GP61 and analyzed for intracellular IFNc and TNFa production by flow
cytometry. Mean 6 SEM (error bars) is shown. For A n = 3 animals per group, for (B) n = 2–3 animals per group, representative of two independent
experiments. (C) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/6 mice depleted of CD8+ T cells receiving 107 naive SMARTA splenocytes were
infected with LCMV. On day 11 after infection, CD4+ splenocytes were restimulated in vitro for 5 h with GP61 and analyzed for intracellular IFNc and
TNFa production by flow cytometry. Mean 6 SEM (error bars) of 2–3 animals per group is shown.
doi:10.1371/journal.pone.0024772.g001
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(FOL I) B cells, and (iii) IgMhighIgDhigh B cells containing follicular
type II (FOL II) B cells. IgMlowIgDlow B cells contain germinal
center (GC)/memory B cells [19]. Eleven days after infection, the
frequency of IgMhighIgDlow B cells was strongly reduced in
LCMV-infected BL/6 mice when compared to naive controls
(mean of 5.9% versus 26.9%; Fig. 5B). Accordingly, frequencies
and absolute numbers of T1, T2, and MZ B cells were strongly
reduced after LCMV infection (Fig. 5C–D). In contrast,
frequencies and absolute numbers of B cells with an IgMlowIgD-
high, IgMhighIgDlow or IgMhighIgDhigh phenotype (FOL I, FOL II,
and GC/memory B cells) remained similar or were increased (Fig.
5B–D). CD8-T cell depletion prevented the loss of B cells with
IgMhighIgDlow phenotype (mean frequency 22.1%, Fig. 5B), and
frequencies and absolute numbers of T1, T2 and MZ B cells were
similar to naı¨ve BL/6 mice (Fig. 5C–D).
Interestingly, the transfer of LCMV-immune CD4+ T cells to
CD8+ T cell-depleted and LCMV-infected mice drastically
reduced the mean frequency of IgMhighIgDlow B cells to 7.5%
(Fig. 5B), a frequency similar to LCMV infected BL/6 mice.
Accordingly, the transfer of LCMV-immune CD4+ T cells
significantly reduced the frequency of T1, T2, and MZ B cells
when compared to CD8-depleted BL/6 mice (Fig. 5C). Likewise,
absolute numbers per spleen dropped from 1.26106 to 0.046106
for T1 B cells, from 0.466106 to 0.026106 for T2 B cells and from
3.06106 to 1.16106 for MZ B cells after adoptive transfer of
LCMV-immune CD4+ T cells. In contrast, B cells with other
IgMIgD phenotypes (FOL I, FOL II, and GC/memory B cells)
remained unchanged or were increased after transfer of LCMV-
immune CD4+ T cells to CD8-depleted mice.
To analyze if the same effect also occurred after adoptive
transfer of a high frequency of naı¨ve LCMV-specific CD4+ T cells,
we replaced LCMV-immune CD4+ T cells by naı¨ve CD4+ T cells
from SMARTA mice. The adoptive transfer of SMARTA cells to
CD8-depleted mice reduced the mean frequency of IgMhighIgDlow
B cells from 18.4% to 6.5% and the mean absolute number from
8.76106 to 2.56106/spleen (Fig. 5E,F). In contrast, B cell
subgroups with a different IgMIgD phenotype remained un-
changed or were increased (Fig. 5E). In summary, these data
indicate, that CD4+ T cells selectively reduce IgMhighIgDlow B cells
during LCMV infection.
Mechanism of IgMhighIgDlow B cell elimination by
cytotoxic CD4+ T cells
To examine if CD4+ T cells can directly kill IgMhighIgDlow B
cells, naı¨ve B cells were labelled with a low CFSE concentration
(CFSElow) and pulsed with LCMV GP61 peptide, a MHC-class II
restricted epitope. As a control, non-peptide pulsed naı¨ve B cells
were labelled with a 10-fold higher concentration of CFSE
(CFSEhigh). CFSElow and CFSEhigh B cells were injected in a ratio
of 1:1 to LCMV infected BL/6 mice (11 days after infection) or
naı¨ve BL/6 mice. Peptide-specific killing was assessed 18 hours
later and revealed that more than half of LCMV-GP61 pulsed
CD19+ B cells were eliminated (Fig. 6A,B). Elimination after
adoptive transfer of CD4+ T cells included all B cell subtypes and,
compared to naı¨ve BL/6 mice, IgMhighIgDlow B cells in LCMV
infected mice were reduced by approximately 70% (Fig. 6C).
These data indicate that LCMV-GP61 presenting IgMhighIgDlow
B cells are a direct target of cytotoxic CD4+ T cells.
To understand the mechanism of IgMhighIgDlow B cell
reduction by CD4+ T cells, LCMV-immune CD4+ T cells from
mice lacking important effector cytokines and cytolytic pathways
such as IFNc, TNFa, perforin and FasL (gld) were generated for
adoptive transfer experiments. Because virus control is different in
all these knockout mice, purified CD8+ T cells (26107 cells) of
naı¨ve immunocompetent BL/6 mice were adoptively transferred
to all mice before LCMV inoculation. Seventeen days later,
LCMV was not detectable in peripheral blood by conventional in
vitro focus forming assay in all mice (Fig. S2) and CD4+ T cells
produced the effector cytokines IFNc and/or TNFa after
restimulation with GP61 (Fig. S3). Splenocytes of these mice were
then purified for CD4+ T cells by MACS and the number of CD4+
T cells containing 1.86105 IFNc-producing LCMV GP61-specific
CD4+ T cells from TNFa2/2, perforin2/2, FasLgld and BL/6
mice were adoptively transferred to groups of naı¨ve CD8-depleted
BL/6 mice. The number of CD4+ T cells from IFNc2/2 mice was
adjusted for TNFa production. On day 11 after LCMV infection,
B cell subgroups were analyzed as before by flow cytometry. T1,
T2 and MZ B cells were clearly reduced after transfer of CD4+ T
cells from TNFa2/2, IFNc2/2, perforin2/2, or FasLgld mice (Fig.
6D). There was a statistically significant elevated number of T1 B
cells in CD8-depleted mice treated with CD4+ T cells lacking
Figure 2. Virus control by CD8+ and CD4+ T cells. (A) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/6 mice depleted of CD8+ T cells
receiving 1.56107 purified LCM-immune CD4+ T cells were infected with LCMV. On day 11 after infection LCMV virus titer was determined in spleen
and liver by plaque forming assay. Each symbol represents one mouse, data was pooled from 3 independent experiments. Horizontal bar indicates
the mean. (B) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/6 mice depleted of CD8+ T cells receiving 1.56107 purified LCMV-immune CD4+ T
cells were infected with LCMV. Neutralizing antibodies against LCMV in the serum was analyzed on day 8, 55 and 86 after infection. Symbols
represent mean 6 SEM (n = 3).
doi:10.1371/journal.pone.0024772.g002
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Figure 3. Immunofluorescence analysis of B and T cell regions. (A) BL/6 mice, BL/6 mice depleted of CD8+ T cells, and BL/6 mice depleted of
CD8+ T cells receiving 1.56107 purified LCMV-immune CD4+ T cells were infected with LCMV. On day 11 after infection spleen sections were stained
for CD3 (T cells; green), B220 (B cells; red), Laminin (blue), or CD35 (FDCs; green), gp38 (FRCs; red), Desmin (stromal cells, blue), or BP-3 (follicular
stromal cells; red) and Desmin (green). One representative section of 3 mice per group is shown. BL/6 naı¨ve mice served as control. Size bar
represents 100 mm. The top row provides an overview with the rows below showing a higher magnification and consecutive sections. (B) The same
experimental groups as in (A) were analyzed for the expression of CXCL13, CCL21, and CCL19 in the spleen by rtPCR. Each sample was analyzed in
duplicate. Each symbol represents the mean of one animal. Horizontal bars indicate mean.
doi:10.1371/journal.pone.0024772.g003
Immunopathology Induced by CD4+ T cells
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IFNc or FasL in comparison to CD8-depleted mice receiving
control CD4+ T cells from BL/6 mice. However, quantitatively
this difference was only minimal. For T2 and MZ B cells no
difference could be found between the different groups of
adoptively transferred CD4+ T cells.
CD4+ T cell mediated immunopathology in the liver
Similar to the immune responses analyzed in the spleen, IFNc
and TNFa production by LCMV-specific CD4+ T cells was
reduced or even absent in the liver of CD8-depleted mice on day 8
and 11 after infection (Fig. 7A,B). Again, the frequency of IFNc-
and TNFa-producing LCMV-specific CD4+ T cells was restored
after transfer of purified LCMV-immune CD4+ T cells (Fig. 7A,B).
Histological analysis of the liver 11 days after LCMV infection
showed moderate portal-periportal and intralobular mononuclear
inflammation in immuncompetent BL/6 mice (Fig. 7C). In CD8-
depleted LCMV-infected BL/6 mice, mononuclear inflammation
was minimal and restricted to the portal tract with no extension to
the periportal or intralobular region. In contrast, adoptive transfer
of LCMV-immune CD4+ T cells resulted in a low to moderate
portal-periportal and intralobular mononuclear inflammation.
Elevated levels of serum alanin-aminotransferase (ALT) is an
indicator of liver cell damage. Eleven days after infection, control
BL/6 mice but not CD8-depleted BL/6 mice had elevated ALT
concentrations in the serum (Fig. 7D). The transfer of purified
LCMV-immune CD4+ T cells to CD8-depleted LCMV infected
BL/6 recipients resulted in elevated ALT levels (Fig. 7D). Thus,
CD4+ T cells are able to induce liver cell damage during LCMV
infection. A potential role of CD4+ T cells in causing hepatitis has
already been shown earlier [20], however the mechanism has
never been elucidated. Therefore, we analyzed ALT concentra-
tions in the sera of CD8-depleted LCMV-infected BL/6 mice,
receiving LCMV-immune CD4+ T cells from mice deficient for
important effector cytokine and cytolytic pathways as described
before (see Fig. 6C). The transfer of CD4+ T cells from IFNc2/2,
FasLgld and perforin2/2 mice but not from TNFa2/2 mice
Figure 4. Immunohistochemistry analysis of the marginal zone. (A,B) BL/6 mice, BL/6 mice depleted of CD8+ T cells, and BL/6 mice depleted
of CD8+ T cells receiving 1.56107 purified LCMV-immune CD4+ T cells were infected with LCMV. On day 11 after infection, spleen sections were
stained for ER-TR9 (MZM) and MOMA-1 (MOMA) and the number of ER-TR9 and MOMA-1 positive cells was counted. For (A) one representative
section of 3 mice per group is shown. For (B) number was counted in each staining in at least 5 microscopic visual fields (206magnification) per
mouse (n = 3). Data expressed as mean 6 SEM (error bar).
doi:10.1371/journal.pone.0024772.g004
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Figure 5. Analysis of the effect of CD4+ T cells on B cell subsets in spleen. (A) Example of splenic B cell subtype analysis. Single cell
suspension of the spleen was first gated on lymphocytes by forward and side scatter and afterwards on CD19+ B cells. CD19+ B cells were divided in
IgMlowIgDlow GC/memory B cells, T1 B cells (CD19+IgMhighIgDlowCD93/AA4+CD232), T2 B cells (CD19+IgMhighIgDlowCD93/AA4+ CD23+), MZ B cells
(CD19+IgMhighIgDlowCD93/AA42CD232), FOL I B cells (CD19+IgMlowIgDhighCD21/35int), and FOL II B cells (CD19+IgMhighIgDhighCD93/AA42/lowCD21/
35int) cells. (B–D) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/6 mice depleted of CD8+ T cells receiving 1.56107 purified LCMV-immune
Immunopathology Induced by CD4+ T cells
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resulted in a significant increase in serum ALT levels (Fig. 7E). Of
note, the magnitude of the increase in serum ALT levels is directly
related to the number of adoptively transferred LCMV-immune
CD4+ T cells. The lower number of transferred CD4+ T cells from
BL/6 mice (1.16107/mouse) in the experiment shown in Fig. 7E
explains the relatively moderate increase of serum ALT levels
when compared to figure 7D, where 1.56107 CD4+ T cells were
adoptively transferred.
Discussion
Infection with LCMV causes T cell mediated immunopathol-
ogy. Dependent on the dose and tropism of the virus, this results in
destruction of lymphoid organ architecture, choriomeningitis,
and/or hepatitis [1,2]. Destruction of lymphoid organ architecture
was mainly attributed to CD8+ T cells, because it was prevented
by CD8-depletion [1]. However, in the absence of CD8+ T cells,
Figure 6. Effector mechanisms of CD4+ T cell-mediated immunopathology. (A) Naı¨ve B cells were pulsed with LCMV GP61 peptide and
labelled with a low concentration of CFSE (CFSElow). Non-peptide pulsed naı¨ve B cells were used as controls and labelled with a 10-times higher
concentration of CFSE (CFSEhigh). CFSElow and CFSEhigh B cells were injected in a ratio of 1:1 to LCMV infected (day 11) BL/6 mice or naı¨ve BL/6 mice
and analyzed 18 hours later in the spleen by flow cytometry. (A) Representative example of each group. (B) The ratio of CFSElow/CFSEhigh CD19+ B
cells was calculated. (C) Percentage of IgMhighIgDlow B cells within CD19+ B cells was determined. Values of naı¨ve BL/6 mice were taken as 100%. (D)
BL/6 mice, BL/6 mice depleted of CD8+ T cells, and BL/6 mice depleted of CD8+ T cells receiving 1.86105 LCMV-GP61-restricted IFNc-producing
splenocytes of BL/6, TNFa2/2, FasLgld or perforin2/2 mice or 1.86105 LCMV-GP61-restricted TNFa-producing splenocytes of IFNc2/2 mice were
infected with LCMV. Eleven days after infection the absolute number of T1, T2 and MZ B cells per spleen was analyzed in the spleen. Mean 6 SEM
(error bars) is shown (n = 3). Statistical analysis was calculated between mice receiving CD4+ T cells from BL/6 mice and mice receiving CD4+ T cells
from TNFa2/2, IFNc2/2, FasLgld or perforin2/2 mice.
doi:10.1371/journal.pone.0024772.g006
CD4+ T cells were infected with LCMV. On day 11 after infection B cell subsets were analyzed as described in (A). (B) Analysis of IgM and IgD subtypes.
Numbers indicate percentage (mean) within CD19+ B cells (n = 3 per group). (C) Percentage within CD19+ B cells and (D) absolute number of T1, T2,
MZ, FOL I, and FOL II, and GC/memory B cells in the spleen. BL/6 naı¨ve mice served as control. Mean 6 SEM (error bars) of 3 animals per group is
shown. For B–D, one representative experiment of 3 independent experiments is shown. (E, F) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/
6 mice depleted of CD8+ T cells receiving 16107 splenocytes of naı¨ve SMARTA mice were infected with LCMV. On day 11 after infection, CD19+
splenocytes were analyzed for IgM and IgD subtypes. (E) Percentage (numbers indicate mean) within CD19+ B cells and (F) absolute number of
IgMlowIgDhigh, IgMhighIgDhigh, IgMhighIgDlow and GC/memory B cells were determined per spleen. Mean 6 SEM (error bars) of 2–3 animals per group
are shown.
doi:10.1371/journal.pone.0024772.g005
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Figure 7. CD4+ T cell-mediated destruction of liver tissue. (A–D) BL/6 mice, BL/6 mice depleted of CD8+ T cells and BL/6 mice depleted of
CD8+ T cells receiving 1.56107 purified LCMV-immune CD4+ T cells i.v. at day 0, were all infected with LCMV. On day 8 (A) and 11 (B) after infection,
CD4+ lymphocytes isolated from the liver were restimulated in vitro for 5 h with GP61 and analyzed for intracellular IFNc and TNFa production by
flow cytometry. (C) On day 11 after infection, liver sections (H&E staining) were analyzed. One representative example of 2–3 mice per group is
shown. Image shows portal tract. Asterix: portal vein. Arrow: bile duct. (D) Level of ALT was measured in the serum. (E) BL/6 mice, BL/6 mice depleted
of CD8+ T cells, and BL/6 mice depleted of CD8+ T cells receiving 1.86105 LCMV-GP61-restricted IFNc-producing splenocytes of BL/6, TNFa2/2, FasLgld
or perforin2/2 mice or 1.86105 LCMV-GP61-restricted TNFa-producing splenocytes of IFNc2/2 mice were infected with LCMV. Eleven days after
infection, level of ALT was measured in the serum. For (A,B,D,E) mean 6 SEM of three mice per group are shown. Statistical analysis was calculated
between mice receiving CD4+ T cells from BL/6 mice and mice receiving CD4+ T cells from TNFa2/2, IFNc2/2, FasLgld or perforin2/2 mice.
doi:10.1371/journal.pone.0024772.g007
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LCMV persists at high titers and leads to functional inactivation
and exhaustion of CD4+ T cells [13]. Therefore, the role of CD4+
T cells in the destruction of lymphoid architecture has never been
investigated so far. To avoid functional inactivation of LCMV-
specific CD4+ T cells, we used two different approaches. We
adoptively transferred either purified LCMV-immune CD4+ T
cells or naı¨ve LCMV-GP61 specific (SMARTA) CD4+ T cells to
CD8-depleted mice. These experiments clearly revealed that
CD4+ T cells can induce immunopathology in spleen and liver.
LCMV-immune CD4+ T cells that are transferred to naı¨ve BL/6
mice and rechallenged with LCMV may behave differently than
endogenous activated CD4+ T cells. Therefore, we repeated the
experiments with adoptive transfer of naı¨ve SMARTA CD4+ T
cells. The immunopathological sequel after transfer of naı¨ve
SMARTA CD4+ T cells was comparable to LCMV-immune
polyclonal CD4+ T cells. This suggests that the persistence of
functional CD4+ T cells in CD8+ T cell depleted hosts is rather a
consequence of the increased LCMV-specific CD4+ T cell
precursor frequency than the activation status.
Interestingly, CD4+ T cells selectively destroyed the marginal
zone, whereas complete disruption of B- and T cell regions only
occurred in CD8-competent control mice. This indicates that part
of the immunopathological sequel, such as the destruction of the
splenic marginal zone, can be mediated by CD4+ T cells, whereas
others depend on the presence of functional CD8+ T cells.
Accordingly, functional CD4+ T cells reduced IgMhighIgDlow T1,
T2 and MZ B cells, whereas B cells with a different IgM/IgD
phenotype (FOL I, FOL II, GC/memory B cells) remained largely
stable. Whereas little is known about the role of T1 and T2 B cells
in immune response, it is well documented that MZ B cells are
crucial for the induction of T cell-independent and T cell-
dependent antibody responses [21,22,23]. Therefore, the observed
reduction of T cell dependent LCMV-specific neutralizing
antibodies after transfer of CD4+ T cells may be a result of
reduced MZ B cells. In agreement with this hypothesis, mice
lacking MZ B cells showed a reduced IgG antibody response
against T cell-dependent antigens such as Borrelia burgdorferi [24]. In
addition, (CD169+) marginal zone metallophilic macrophages
(MOMA) are essential for the initiation of antiviral B cell response
[25]. Since MOMA are also reduced by CD4+ T cells, this may
further contribute to the reduction in neutralizing antibody titers.
A correlation of CD4+ T cell activity with reduced and delayed
neutralizing antibody responses to LCMV has already been
reported earlier [26]. This was attributed to competition on
survival factors or anatomical niches due to a CD4+ T cell induced
polyclonal B cell activation and hypergammaglobulinemia.
However, our earlier experiments showed that higher titers of
LCMV-neutralizing antibodies were produced in CD27-deficient
mice than in BL/6 mice despite of higher gammaglobulin levels in
CD27-deficient mice [16].
The integrity of the splenic marginal zone is dependent on
several chemokines. Marginal zone macrophage localization is
regulated by CCL19 and CCL21 [27] and activated marginal
zone B cells are attracted by CXCL13 [22]. CD8-depleted BL/6
mice had a strongly reduced expression of CCL21, CCL19 and
CXCL13. However, CD4+ T cells did not further affect the
expression of these chemokines. This is in accordance with our
results that stromal cells (FDCs and FRCs) producing these
chemokines were not reduced in numbers after transfer of CD4+ T
cells. Together, this indicates that CD4+ T cell mediated
destruction of the splenic marginal zone is not a result of changes
in chemokine expression. Our experiments with peptide pulsed
and CFSE labelled B cells rather indicate that MZ B cells are
eliminated directly by cytotoxic CD4+ T cells. By virtue of their
abundant expression of MHCII and costimulatory molecules, MZ
B cells are efficient antigen presenting cells for CD4+ T cells [23].
While presenting LCMV-specific antigens to CD4+ T cells, MZ B
cells probably become a direct target of activated CD4+ T cells.
Interestingly, CD4+ T cell mediated elimination of MZ B cells did
not reduce virus titers in the spleen. This is in accordance with
current evidence that B cells are not infected directly by LCMV
but capture and present exogenous antigen [28]. Similarly,
MOMA may also be a direct target of cytotoxic CD4+ T cells,
as they constitute a reservoir for LCMV replication [29] and
express MHCII molecules [25]. However, resident cells of the
spleen depend on each other for their localization and mainte-
nance [3]. Therefore, from our results we cannot define which cell
populations of the splenic marginal zone are direct targets of
cytotoxic CD4+ T cells and which cell populations are reduced
indirectly as a consequence of the loss of the integrity of the
marginal zone.
Cytotoxic CD4+ T cells have been reported after infection with
various pathogens and several mechanisms of cytotoxicity have
been described. These include i) Fas/FasL in EBV [30]- and
LCMV [31]-infection, ii) perforin in influenza [32], EBV [33] and
HIV [34] infection and iii) IFNc in gammaherpesvirus 68 infection
[35]. We could not define a single pathway responsible for CD4+
T cell mediated reduction of IgMhighIgDlow B cells in our
experimental set-up. Although T1 B cell lysis seemed to depend
in part on IFNc and Fas-FasL interaction, the difference to the
control group was small, indicating that each of this single effector
pathway by its own is of minor physiological importance. In
contrast, an earlier publication showed that B cells were killed after
LCMV infection by CD4+ T cells in a Fas-Fas ligand mechanism
[31]. However, that study analyzed adoptively transferred naive B
cells labelled with GP61 peptide, which can not directly be
compared to our study analyzing activated B cells in the course of
a LCMV infection.
Liver enzyme levels after LCMV infection are not elevated in
CD8-depleted BL/6 mice suggesting that CD8+ T cells are the only
cells responsible for liver cell damage. However, our experiments
suggest that CD4+ T cells also play a role in the induction of
hepatitis. As hepatocytes are infected by LCMV and upregulate
MHCII molecules after LCMV infection, ours and earlier
experiments [20] indicate that they may become a direct target of
cytotoxic CD4+ T cells. However, as for the spleen, we cannot
exclude that secondary effects are involved in liver cell damage, e.g.
activation of Kupffer cells, macrophages, or of hepatotoxic NK/
NKT cells by CD4+ T cells [36,37]. Our experiments revealed that
the induction of hepatitis by CD4+ T cells depended at least in part
on TNFa. Therefore, CD4+ T cells are involved in immunopath-
ological sequel in various organs, but the relative importance of the
cytolytic pathways may depend on the organ analyzed.
In several widespread human pathogens such as Plasmodium
falciparum (malaria) [6], Leishmania donovani [8], Lassa virus [7] and
HIV [5,38] lymphoid architecture is destroyed and consequently
the host’s immune system is suppressed. Further studies will be
necessary to evaluate the contribution of CD4+ T cells in
immunopathology in these infections, especially in viral infections
that are characterized by a late and inefficient induction of
neutralizing Abs, such as HIV and HCV. As a parallel to LCMV,
a reduction of marginal zone B cells has been documented in HIV
infection [39] and interestingly, early hyperactivity of CD4+ T cells
is a risk factor for disease progression after HIV infection [40].
Likewise, a strong T helper cell response was associated with low
neutralizing antibodies after HCV infection [41]. Therefore,
understanding the mechanisms of lymphoid destruction in
different infections may help to design novel therapies.
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Materials and Methods
Ethics statement
Animal experiments were carried out in strict accordance with
the regulations of the Veterinary office of the Canton Bern
(Switzerland) and the Swiss Animal Protection Law. The protocol
was approved (Permit Number: 84-08) by the Veterinary office of
the Canton Bern.
Mice
C57BL/6 (BL/6) mice were purchased from Harlan (Amster-
dam, Netherlands). SMARTA transgenic mice, IFNc2/2 and
Perforin2/2 mice were obtained from the Institute for Laboratory
Animals (Zurich, Switzerland). TNFa2/2 mice were from C.
Mu¨ller (Bern, Switzerland) and FasL-deficient FasLgld mice from
N. Corazza (Bern, Switzerland).
Viruses and peptide
LCMV-WE was from R. M. Zinkernagel (Zurich, Switzerland)
and was propagated on L929 fibroblast cells. If not indicated
differently 106 pfu LCMV-WE was used for all experiments. The
LCMV glycoprotein peptide amino acid GP61 (GLNGPDIYKG-
VYQFKSVEFD) was purchased from NeoMPS SA (Strasbourg,
France).
Detection of virus and neutralizing antibody titers
The detection of LCMV titer and neutralizing antibodies has
been described earlier [42].
Immunofluorescence and immunohistochemistry
Tissues were embedded in optimum cutting temperature
compound (O.C.T medium, Tissue-Tek, Sakura) without prior
fixation and snap-frozen. For immunofluorescence, cryostat
sections (8 mm in thickness) were stained as previously described
[43], and acquired on an Axioplan microscope with AxioCam
MRm (Zeiss) or on a DM IRE2 microscope with a laser-scanning
confocal head TCS SP2 acousto-optical beam splitter (Leica). For
immunohistochemistry, cryostat sections of 5-mm thickness were
treated as described [44] and stained with rat monoclonal
antibodies against metallophilic marginal zone macrophages
(MOMA-1; BMA Biomedicals AG, Augst, Switzerland) and ER-
TR9 [45].
CD8+ T cell depletion
Mice were treated intraperitoneally (i.p.) with 200 mg of aCD8
mAb (YTS169.4, bioXcell, West Lebanon, NH) on days 0, 1, 3, 5,
7 and 10 after adoptive transfer of CD4+ T cells and LCMV
infection. Efficiency of depletion was verified by flow cytometry
analysis.
Antibodies and flow cytometry
aCD4-PE, aCD4-PE-Cy5, aCD19-FITC, aCD19-APC-Cy7,
aIgD-PE, aIgM-PE-Cy7, aCD93/AA4-APC, aCD23-Biotin,
aCD21/35-FITC, aIFN-c-FITC, aTNFa-PE, were purchased
from eBioscience (San Diego, CA). For intracellular staining,
lymphocytes (106/wells) were stimulated with GP61 peptide (at
1026 M per well) in the presence of recombinant IL-2 (25 U/ml,
ProSpec, Rehovot, Israel) and 5 mg/ml Brefeldin A (Sigma-
Aldrich, Switzerland) for 5 hours. Cells were stained for surface
molecules, fixed with 4% paraformaldehyde in PBS, and then cell
membranes were permeabilized with Perm-Buffer (PBS, 2% FCS,
5 mM EDTA, 0.1% saponin, 0.2% NaN3) and stained with
aIFNc-FITC or aTNFa-PE. Relative fluorescence intensities were
measured with a FACScanTM or BDTM LSRII (BD, Mountain
View, CA) and analyzed using FlowJoTM software (Tree Star,
Ashland, OR).
Purification of LCMV-immune CD4+ T cells
BL/6 mice were infected with 200 pfu LCMV-WE. 17 days
later splenocytes were harvested and enriched for CD4+ T cells by
positive selection with MACS (Miltenyi Biotec, Bergisch Glad-
bach, Germany) and were adoptively transferred i.v. to recipient
mice. The purity of CD4+ T cells was $90%.
Isolation of hepatic lymphocytes
To isolate hepatic lymphocytes, liver was removed, and cut in
small pieces. Afterwards liver was digested with BSS containing
2% FCS, 0.6% BSA, 5 mM CaCl2, 5 mM MgCl2, 1 mg/ml
collagenase Type IA (Sigma-Aldrich), 20 mg/ml DNase I (Roche)
for 15 min at 37uC. In a next step, liver was filtered through a
sterile 40-mm nylon cell strainer (BD Biosciences) and washed once
with BSS before erythrocytes were removed by Puregene red
blood cell lysis solution (Qiagen). Finally, lymphocytes were
isolated by Ficoll gradient centrifugation (Ficoll-PaquePlus, Amer-
sham Biosciences, Uppsala, Sweden).
Real time RT PCR of chemokines
Spleens were shock frozen and disrupted in Trizol. RNA was
isolated according to manufacture guidelines (Invitrogen) and real
time PCR analysis was performed using QuantiFast SYBR Green
(Eurogentech) PCR kit. The following primer combination was
used: GAPDH forward 59 CCA CCC CAG CAA GGA GAC T
and GAPDH reverse 59 GAA ATT GTG AGG GAG ATG CT;
Ccl19-atg 59 -CTG CCT CAG ATT ATC TGC CAT- 39 and 59 -
AGG TAG CGG AAG GCT TTC AC- 3; Ccl21-ser 59 -ATC
CCG GCA ATC CTG TTC TC- 39 and 59 -GGT TCT GCA
CCC AGC CTT C- 39; CXCL13 59- GAG GCT CAG CAC
AGC AAC-39 and 59-TTG AAA TCA CTC CAG AAC ACC
TAC A- 39.
Alanine aminotransferase
We measured ALT with a serum multiple biochemical analyzer
(cobasH 8000 modular analyser, Roche, Switzerland).
Statistical evaluation
For statistical analysis Graph Pad Prism Version 5 (GraphPad
Software) was used. Significances were tested using an unpaired,
two-tailed student’s t-test. Data was considered statistically
significant when p-value was ,0.05. Symbol * means p,0.05,
ns = not significant.
Supporting Information
Figure S1 Immunofluorescence analysis of CXCL13 and
CCL21 protein expression. (A) BL/6 mice, BL/6 mice
depleted of CD8+ T cells, and BL/6 mice depleted of CD8+ T
cells receiving 1.56107 purified LCMV-immune CD4+ T cells
were infected with LCMV. On day 11 after infection spleen
sections were stained for CXCL13 protein (red), and Laminin
(blue), or CCL21 protein (green). TZ: T cell zone, BZ: B cell zone.
Arrows show sites of CXCL13 expression co-localizing frequently
with laminin-expressing cells in LCMV-exposed spleens. Large
dots in the red pulp are artifactual staining of cells expressing
endogenous HRP. One representative section of 3 mice per group
is shown. BL/6 naı¨ve mice served as control. Size bar represents
100mm.
(TIF)
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Figure S2 Virus control in mice deficient in T cell
effector mechanisms. 26107 CD8+ T cells from naı¨ve BL/6
mice were adoptively transferred to IFNc-/-, TNFa-/-, perforin-/-
and FasLgld deficient mice before infection with 200 pfu LCMV.
Seventeen days after infection, virus titer was measured by plaque
forming assay of the peripheral blood from all mice. Each symbol
represents one mouse. As an assay control LCM virus with a titer
of 36107pfu/ml was taken.
(TIF)
Figure S3 IFNc and TNFa production in mice deficient
in T cell effector mechanisms. 26107 CD8+ T cells from
naı¨ve BL/6 mice were adoptively transferred to IFNc-/-, TNFa-/-,
perforin-/- and FasLgld deficient mice before infection with 200 pfu
LCMV. Seventeen days after infection, CD4+ T lymphocytes from
the spleen were restimulated in vitro for 5h with p13 and analyzed
for intracellular IFNc and TNFa production by flow cytometry.
Numbers indicate percentage (mean, n = 3) of CD4+ T cells
producing IFNc and TNFa.
(TIF)
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